Vista Finance LLC Takes Position in Addus HomeCare Co. (NASDAQ:ADUS)

Vista Finance LLC purchased a new position in Addus HomeCare Co. (NASDAQ:ADUSFree Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 2,799 shares of the company’s stock, valued at approximately $351,000. Addus HomeCare makes up about 0.4% of Vista Finance LLC’s holdings, making the stock its 27th largest holding.

A number of other hedge funds have also recently added to or reduced their stakes in ADUS. Creative Planning boosted its holdings in shares of Addus HomeCare by 5.8% in the 3rd quarter. Creative Planning now owns 4,910 shares of the company’s stock valued at $653,000 after purchasing an additional 267 shares during the last quarter. Net Worth Advisory Group acquired a new position in Addus HomeCare in the third quarter valued at $356,000. Allspring Global Investments Holdings LLC grew its position in Addus HomeCare by 48.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 70,231 shares of the company’s stock valued at $9,343,000 after acquiring an additional 22,900 shares during the period. Argent Capital Management LLC increased its stake in Addus HomeCare by 5.2% during the third quarter. Argent Capital Management LLC now owns 39,257 shares of the company’s stock worth $5,222,000 after acquiring an additional 1,947 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Addus HomeCare by 5.6% in the 3rd quarter. Assenagon Asset Management S.A. now owns 108,314 shares of the company’s stock worth $14,409,000 after purchasing an additional 5,719 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock worth $4,930,750 in the last 90 days. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $113.22 on Friday. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.72. The stock’s 50-day simple moving average is $126.04 and its 200-day simple moving average is $127.08. The firm has a market cap of $2.05 billion, a price-to-earnings ratio of 25.91, a PEG ratio of 1.55 and a beta of 1.00.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Oppenheimer increased their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. JMP Securities began coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. Finally, StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $134.22.

Read Our Latest Research Report on ADUS

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.